Screening for cervical cancer in the era of the HPV vaccine--the urgent need for both new screening guidelines and new biomarkers.
Kiviat
Nancy B
NB
Hawes
Stephen E
SE
Feng
Qinghua
Q
D000367:Age Factors; D052685:Alphapapillomavirus / Q000235:genetics / Q000302:isolation & purification*; D014408:Biomarkers, Tumor / Q000378:metabolism*; D003362:Cost-Benefit Analysis; D004279:DNA, Viral / Q000302:isolation & purification; D005260:Female; D006801:Humans; D008403:Mass Screening / Q000191:economics* / Q000379:methods* / Q000592:standards; D017059:Models, Econometric; D053918:Papillomavirus Vaccines / Q000008:administration & dosage; D017410:Practice Guidelines as Topic; D014481:United States; D002583:Uterine Cervical Neoplasms / Q000191:economics / Q000517:prevention & control* / Q000821:virology
D014408:Biomarkers, Tumor; D004279:DNA, Viral; D053918:Papillomavirus Vaccines